- Home
- GOVX vs ZDAI Comparison
GOVX vs ZDAI Comparison
Compare GOVX & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- ZDAI
- Stock Information
- Founded
- GOVX 2001
- ZDAI 2022
- Country
- GOVX United States
- ZDAI Hong Kong
- Employees
- GOVX N/A
- ZDAI N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- Sector
- GOVX Health Care
- ZDAI Consumer Discretionary
- Exchange
- GOVX Nasdaq
- ZDAI Nasdaq
- Market Cap
- GOVX 16.8M
- ZDAI 14.8M
- IPO Year
- GOVX N/A
- ZDAI 2024
- Fundamental
- Price
- GOVX $0.41
- ZDAI $0.37
- Analyst Decision
- GOVX Strong Buy
- ZDAI
- Analyst Count
- GOVX 2
- ZDAI 0
- Target Price
- GOVX $7.00
- ZDAI N/A
- AVG Volume (30 Days)
- GOVX 524.6K
- ZDAI 2.3M
- Earning Date
- GOVX 11-13-2025
- ZDAI 12-09-2025
- Dividend Yield
- GOVX N/A
- ZDAI N/A
- EPS Growth
- GOVX N/A
- ZDAI N/A
- EPS
- GOVX N/A
- ZDAI N/A
- Revenue
- GOVX $3,353,560.00
- ZDAI $19,275,673.00
- Revenue This Year
- GOVX N/A
- ZDAI N/A
- Revenue Next Year
- GOVX N/A
- ZDAI N/A
- P/E Ratio
- GOVX N/A
- ZDAI N/A
- Revenue Growth
- GOVX 8.52
- ZDAI 43.16
- 52 Week Low
- GOVX $0.37
- ZDAI $0.35
- 52 Week High
- GOVX $3.01
- ZDAI $107.36
- Technical
- Relative Strength Index (RSI)
- GOVX 35.66
- ZDAI 35.10
- Support Level
- GOVX $0.37
- ZDAI $0.35
- Resistance Level
- GOVX $0.44
- ZDAI $0.40
- Average True Range (ATR)
- GOVX 0.03
- ZDAI 0.03
- MACD
- GOVX -0.00
- ZDAI 0.00
- Stochastic Oscillator
- GOVX 26.59
- ZDAI 25.91
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.